Biosimilars could pave the way to more affordable options for patients, says CEO of Matrix Global Advisors
Alex Brill, CEO of Washington, D.C.-based economic policy consulting firm Matrix Global Advisors, recently published a strategic proposal suggesting how payors can support biosimilar utilization. Read More »
Alerts Sign-up